Applications of 3-Bromo-4-Hydroxypyridine in Industrial Manufacturing

3-Bromo-4-Hydroxypyridine serves as a specialized intermediate relied upon by advanced chemical manufacturers across pharmaceuticals, agrochemicals, and fine chemical sectors. Our production supports integrated supply chains by ensuring tight control over purity, residual metals, and trace byproducts to meet strict industrial quality standards.

1. Pharmaceutical Intermediate for Antiviral Drug Synthesis

Research-driven pharmaceutical groups utilize 3-Bromo-4-Hydroxypyridine to construct advanced pyridine moieties during synthesis of new-generation antiviral actives. It enters targeted halogenation steps as a precursor, facilitating subsequent coupling or hydroxylation under controlled GMP environments. The unique substitution pattern supports scaffold construction where precise regulatory documentation of trace impurities is demanded by authorities and global partners throughout each scale-up batch.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
• USP <1790>, <467> Residual Solvents testing
• EU GMP Annex 2 for APIs
• FDA 21 CFR Part 211

Typical usage ratio

• 10–25% of the total mole ratio in first-step cyclization; adjusted per molar demand in subsequent transformations

Downstream process integration

• Introduced in the initial halogenated pyridine formation and remains as a building block through N-alkylation stages of antiviral intermediate synthesis workflows

Final product types

• API intermediates for anti-influenza drugs
• Pyridine-based hepatitis C antivirals
• Investigational new drug (IND) candidate compounds

2. Agrochemical Intermediate for Selective Herbicide Synthesis

Leading crop protection companies apply 3-Bromo-4-Hydroxypyridine in the custom production of pyridine carboxamide herbicides targeting resistant weed species. Here, strict traceability of impurities and proper integration with chlorination reactors are required to meet registry submissions for EU and US agrochemical product approvals. The intermediate supports formulation of selective action compounds through sequential coupling and condensation with various amides and hydrocarbons.

Industry compliance standards

• ISO 9001:2015 Quality Management, Agrochemical Plant Certification
• REACH Registration for chemical intermediates
• US EPA Pesticide Registration (CFR Title 40, Part 158)
• FAO Specifications for Pesticide Intermediates

Typical usage ratio

• 5–12% by mass of total batch in condensation or coupling steps; real ratio varies based on targeted herbicide selectivity mode and downstream substrate composition

Downstream process integration

• Consumed during regulated chlorination and subsequent amidation as a core structure provider in high-performance herbicide synthesis lines

Final product types

• Pyridine-based selective herbicides
• Pre-mix technical herbicide actives
• Intermediates for broadleaf crop protection products

3. Advanced Material Synthesis for OLED Intermediate Production

Manufacturers of organic electronic components rely on 3-Bromo-4-Hydroxypyridine to construct key heterocyclic motifs in the synthesis of fine chemicals for OLED emitting-layer intermediates. Purity requirements exceed 99.5% to minimize charge-trapping defects in final optoelectronic layers. The material enters Suzuki-Miyaura and Stille cross-coupling reactions, responding to the need for scalable, consistent sourcing in ISO/TD GMP-certified environments specializing in high-purity electronic intermediates.

Industry compliance standards

• ISO 9001:2015 and ISO 14001:2015
• RoHS (Restriction of Hazardous Substances Directive) compliance for downstream use
• IECQ HSPM QC 080000 for Hazardous Substance Process Management
• REACH-Regulated Substance Assessment (for EU export)

Typical usage ratio

• 3–8% molar addition in cross-coupling feed, tuned to functional group load and targeted emitter performance

Downstream process integration

• Applied during palladium-catalyzed cross-coupling to introduce brominated pyridine into conjugated material backbones for OLED intermediates

Final product types

• Pyridine-derived OLED small molecule intermediates
• Specialty emitting-layer additives for display panels
• OLED ink precursors for fine patterning

4. Pyridine Ring Precursors in Veterinary Drug Ingredient Synthesis

Animal health manufacturers use 3-Bromo-4-Hydroxypyridine in dedicated synthesis of pyridine-based veterinary drug ingredients where international VICH guidelines require documented specifications and full impurity profiling. The intermediate undergoes further transformation through nucleophilic substitution, leading to advanced functionalization for production of actives addressing livestock and companion animal infections.

Industry compliance standards

• VICH GL10 GMP for Active Pharmaceutical Ingredients
• USP Veterinary Drug Monographs
• EU Regulation (EC) No 470/2009 (MRLs for Veterinary Medicine)
• ISO/IEC 17025:2017 for internal labs or approved external QC

Typical usage ratio

• 15–22% in primary nucleophilic substitution or ring assembly operations, with fine-tuning according to the structure of the target animal drug

Downstream process integration

• Utilized in initial step of veterinary pyridine API synthesis; feeds into substitution or reduction contexts before crystallization and purification

Final product types

• Pyridine-based active pharmaceutical ingredients for veterinary medicine
• Intermediate compounds for antiparasitic products
• Finished injectable or oral animal drugs involving halogenated pyridine units